Physician
North Charlotte Pediatrics PLLC
North Charlotte Pediatrics PLLC was paid $2.13M by Medicaid between Jan 2018 and Apr 2020, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoNORTH CHARLOTTE PEDIATRICS PLLC
CHARLOTTE, NC 28262
CHARLOTTE, NC 28262
33aNPI1770735466assigned 10/14/2008
33bProvider typePediatrics Physician
28Total paid$2.13M
24GClaims94,192
24DCodes billed67
24AFirst – last monthJan 2018 – Apr 2020
Compared with peers
Next to other Pediatrics Physician providers in North Carolina
Rank by total paid#153 of 433
Median peer was paid$942K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,780 | $841K | |
| 2019 | 42,234 | $1.10M | |
| 2020 | 7,178 | $186K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 13,139 | 11,060 | $741K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 12% | 3,250 | 2,980 | $255K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.3% | 2,504 | 2,342 | $199K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.3% | 2,466 | 2,171 | $198K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.8% | 2,016 | 1,838 | $166K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.8% | 1,849 | 1,715 | $144K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 4.2% | 3,842 | 3,541 | $90K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4.2% | 6,190 | 5,482 | $90K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 2,556 | 2,380 | $34K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 4,353 | 3,724 | $33K |
| 99050 | 1.5% | 1,329 | 1,185 | $31K | |
| 99381 | 1.4% | 357 | 327 | $29K |
55 more codes
| D0145 | Oral evaluation for a patient under three years of age | 1.1% | 842 | $23K |
| 90474 | <1% | 1,047 | $13K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 531 | $13K |
| D1206 | Topical application of fluoride varnish | <1% | 841 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 982 | $10K |
| 83655 | <1% | 591 | $8K | |
| 90734 | <1% | 887 | $8K | |
| 81002 | <1% | 6,936 | $7K | |
| 90621 | <1% | 444 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,646 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 446 | $4K |
| 85018 | <1% | 3,312 | $3K | |
| 94664 | <1% | 292 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 32 | $3K |
| 96160 | <1% | 642 | $2K | |
| 96127 | <1% | 451 | $1K | |
| 90715 | <1% | 555 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 360 | $1K |
| 99383 | <1% | 18 | $779.20 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 316 | $583.17 |
| 92551 | <1% | 6,235 | $493.72 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 75 | $413.25 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 316 | $410.72 |
| 99173 | <1% | 6,692 | $357.00 | |
| 90633 | <1% | 1,221 | $297.90 | |
| 90716 | <1% | 927 | $278.04 | |
| 81025 | <1% | 49 | $179.40 | |
| 90707 | <1% | 904 | $78.72 | |
| 36416 | 0% | 3,103 | $0.00 | |
| 90723 | 0% | 812 | $0.00 | |
| 84436 | 0% | 43 | $0.00 | |
| 90696 | 0% | 498 | $0.00 | |
| 90744 | 0% | 15 | $0.00 | |
| 90680 | 0% | 1,044 | $0.00 | |
| 90698 | 0% | 279 | $0.00 | |
| 90647 | 0% | 1,047 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 190 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 435 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 72 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 118 | $0.00 |
| 90686 | 0% | 222 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 146 | $0.00 |
| 87081 | 0% | 74 | $0.00 | |
| 90657 | 0% | 56 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 15 | $0.00 |
| 90649 | 0% | 1,250 | $0.00 | |
| 90670 | 0% | 1,604 | $0.00 | |
| 80061 | Lipid panel | 0% | 94 | $0.00 |
| 90700 | 0% | 448 | $0.00 | |
| 99420 | 0% | 352 | $0.00 | |
| 90658 | 0% | 776 | $0.00 | |
| 86756 | 0% | 15 | $0.00 | |
| 90713 | 0% | 13 | $0.00 | |
| 84481 | 0% | 14 | $0.00 | |
| 90648 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSEWANYANA, STEVEN (OWNER)